Therapy News and Research

RSS

IRIDEX to host Speakers' Forum program at the American Academy of Ophthalmology

IRIDEX Corporation (Nasdaq: IRIX) announced today its Speakers' Forum program at the annual meeting of the American Academy of Ophthalmology to be held on October 18 – 21 at McCormick Place in Chicago.

17 Oct 2014

Newly developed agent filters out toxins from body in the event of overdose

Every minute counts in the event of an overdose. ETH professor Jean-Christophe Leroux and his team have developed an agent to filter out toxins from the body more quickly and efficiently.

17 Oct 2014

Statistical analysis shows stage of breast cancer predicts treatment choice

Why did 43 percent of South Dakota women diagnosed with early-stage breast cancer surveyed choose mastectomy rather than lumpectomy?

17 Oct 2014

New oral biologic medication successfully treats precancerous intestinal inflammation

An oral biologic medication has successfully treated chronic, precancerous inflammation in the intestine, according to results of an animal study authored by an MD/PhD student in the University at Buffalo School of Medicine and Biomedical Sciences.

16 Oct 2014

Cell transplantation treatment may benefit people with spinal cord injury

Two studies recently published in Cell Transplantation reveal that cell transplantation may be an effective treatment for spinal cord injury (SCI), a major cause of disability and paralysis with no current restorative therapies.

16 Oct 2014

CHLA pediatric specialist discusses how parents can help children prevent Ebola outbreak

For many months, the world has witnessed the Ebola virus spread and claim more than 4,400 lives in West African countries. On Oct. 8, the first confirmed adult Ebola patient identified in the United States died. The constant news coverage has heightened concern among parents who fear their children will become infected. Jill Hoffman, MD, a pediatric Infectious diseases specialist at Children's Hospital Los Angeles, discusses the facts about Ebola, how parents can help their children prevent further outbreak by teaching them good hygiene, and how CHLA is prepared to identify and treat suspected Ebola patients.

16 Oct 2014

Rose Medical Center experts perform LARIAT procedure for patients with atrial fibrillation

Rose Medical Center is now performing a groundbreaking procedure for patients with atrial fibrillation (AFib) that may reduce their risk for stroke when they cannot take blood thinners due to special circumstances.

16 Oct 2014

New combination therapy shows promise in treating prostate cancer

Like discriminating thieves, prostate cancer tumors scavenge and hoard copper that is an essential element in the body. But such avarice may be a fatal weakness.

16 Oct 2014

Union Hospital expands use of capnography to strengthen patient safety

Union Hospital recently strengthened patient safety measures by expanding its use of capnography to monitor patients capnography during patient-controlled analgesia (PCA) to regulate their pain after surgery.

16 Oct 2014

Otoharmonics receives Class 2 medical device license for Levo system from Health Canada

Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.

16 Oct 2014

SOFIE BIOSCIENCES awarded NCI Phase II SBIR contract to develop [18F]FAC PET

SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years.

16 Oct 2014

Health Media Network to use SITO's mobile advertising platform to improve healthcare outcomes

SITO Mobile Ltd., a leading mobile media solutions provider, and Health Media Network (HMN), one of the nation's fastest growing digital Point of Care media companies, today announced a partnership by which Health Media Network will leverage SITO Mobile's mobile media platform to power a national location-based advertising network within physician offices nationwide.

16 Oct 2014

PAP therapy reduces 30-day hospital readmission rates in cardiac patients with sleep apnea

A study of hospitalized cardiac patients is the first to show that effective treatment with positive airway pressure therapy reduces 30-day hospital readmission rates and emergency department visits in patients with both heart disease and sleep apnea.

16 Oct 2014

New study reveals ways to reduce HIV rates in Mexico

To address the HIV epidemic in Mexico is to address it among men who have sex with men (MSM), because they account for a large percentage of the country's new infections, says Omar Galárraga, assistant professor of health services policy and practice in the Brown University School of Public Health.

16 Oct 2014

TxCell to provide overview of T cellular therapy at 7th National Bio-Therapy Conference

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present on T cellular therapy for autoimmune diseases at the 7th National Bio-Therapy Conference, October 24-26, 2014 at Great Tang Hotel, Shanghai, China.

16 Oct 2014

Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

Heart failure is a debilitating, and life-threatening, condition in which the heart cannot pump enough blood around the body. When heart failure continues to progress and worsen over time, the persistent condition is known as chronic heart failure.

From Novartis 16 Oct 2014

New study reviews modern treatment modalities for early-stage lung cancer

Removal of the entire lobe of lung may offer patients with early-stage lung cancer better overall survival when compared with a partial resection, and stereotactic ablative radiotherapy (SABR) may offer the same survival benefit as a lobectomy for some patients, according to a study from The University of Texas MD Anderson Cancer Center.

16 Oct 2014

Coordinated care by physician anesthesiologists can benefit knee replacement patients

Knee replacement patients go home sooner, are highly satisfied and incur less cost when a physician anesthesiologist coordinates care, suggests research presented at the ANESTHESIOLOGY™ 2014 annual meeting.

16 Oct 2014

Federal prescription-subsidy program improves drug adherence in breast cancer patients

A federal prescription-subsidy program for low-income women on Medicare significantly improved their adherence to hormone therapy to prevent the recurrence of breast cancer after surgery.

16 Oct 2014

Scientists combine new type of nanoparticle with photodynamic therapy to kill cancer cells

An international group of scientists led by Gang Han, PhD, at the University of Massachusetts Medical School, has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to effectively kill deep-set cancer cells in vivo with minimal damage to surrounding tissue and fewer side effects than chemotherapy. This promising new treatment strategy could expand the current use of photodynamic therapies to access deep-set cancer tumors.

16 Oct 2014

Therapy News and Research

IRIDEX to host Speakers' Forum program at the American Academy of Ophthalmology

Newly developed agent filters out toxins from body in the event of overdose

Statistical analysis shows stage of breast cancer predicts treatment choice

New oral biologic medication successfully treats precancerous intestinal inflammation

Cell transplantation treatment may benefit people with spinal cord injury

CHLA pediatric specialist discusses how parents can help children prevent Ebola outbreak

Rose Medical Center experts perform LARIAT procedure for patients with atrial fibrillation

New combination therapy shows promise in treating prostate cancer

Union Hospital expands use of capnography to strengthen patient safety

Otoharmonics receives Class 2 medical device license for Levo system from Health Canada

SOFIE BIOSCIENCES awarded NCI Phase II SBIR contract to develop [18F]FAC PET

Health Media Network to use SITO's mobile advertising platform to improve healthcare outcomes

PAP therapy reduces 30-day hospital readmission rates in cardiac patients with sleep apnea

New study reveals ways to reduce HIV rates in Mexico

TxCell to provide overview of T cellular therapy at 7th National Bio-Therapy Conference

Reducing heart failure deaths: an interview with Dimitrios Georgiopoulos, UK Medical Director, Novartis

New study reviews modern treatment modalities for early-stage lung cancer

Coordinated care by physician anesthesiologists can benefit knee replacement patients

Federal prescription-subsidy program improves drug adherence in breast cancer patients

Scientists combine new type of nanoparticle with photodynamic therapy to kill cancer cells

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News